دورية أكاديمية

Association between CRT(D)/ICD and renal insufficiency: A systematic review and meta‐analysis.

التفاصيل البيبلوغرافية
العنوان: Association between CRT(D)/ICD and renal insufficiency: A systematic review and meta‐analysis.
المؤلفون: Liu, Ying, Sun, Jin‐Yu, Zhu, Yu‐Shan, Li, Zi‐Meng, Li, Ku‐Lin, Wang, Ru‐Xing
المصدر: Seminars in Dialysis; Jan/Feb2021, Vol. 34 Issue 1, p17-30, 14p, 1 Diagram, 7 Charts, 1 Graph
مصطلحات موضوعية: KIDNEY failure, CARDIAC pacing, CHRONIC kidney failure, IMPLANTABLE cardioverter-defibrillators, EPIDERMAL growth factor receptors
مستخلص: Cardiac resynchronization therapy with or without a defibrillator (CRT(D)) and implantable cardioverter defibrillator (ICD) may reduce the risk of arrhythmia or heart failure‐specific mortality and improves the prognosis of patients with chronic kidney disease (CKD) or dialysis. The aim of this study was to perform a meta‐analysis investigating the relationship between CRT(D)/ICD and renal insufficiency. Cochrane Library, Web of Science, Embase, and Pubmed were systematically searched from inception to 29 October 2019. We included studies that report all‐cause mortality of patients with renal insufficiency who received CRT(D)/ICD therapy. Twenty‐six studies (n = 119,263) were included, exploring the relationship between CRT(D)/ICD and renal insufficiency from two aspects: (1) Compared with ICD‐only, CRT(D) was associated with lower risk of all‐cause mortality in CKD patients (odds ratios (OR) = 0.67; 95% confidence interval (CI), 0.60 to 0.75). For non‐primary prevention (secondary prevention or both), the analysis revealed a lower risk of all‐cause mortality in the ICD group than in the no‐ICD group (OR = 0.47; 95% CI, 0.40 to 0.55). (2) CKD increased all‐cause mortality in comparison with control group (OR = 2.12; 95% CI, 1.85 to 2.44), and so did dialysis (OR = 2.53; 95% CI, 2.34 to 2.73). Furthermore, compared with CKD3 (eGFR: 30‐59 ml/min/1.73 m2), CKD4/5 (eGFR <30 ml/min/1.73 m2) was observed to have a significantly higher risk of all‐cause mortality (OR = 2.70; 95% CI, 1.93 to 3.80). This review shows a clear association between CRT(D)/ICD and renal insufficiency in the aspect of all‐cause mortality, and may provide a reference for the clinical application of CRT(D)/ICD. [ABSTRACT FROM AUTHOR]
Copyright of Seminars in Dialysis is the property of Wiley-Blackwell and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
قاعدة البيانات: Complementary Index
الوصف
تدمد:08940959
DOI:10.1111/sdi.12937